Reaction
Blood Uric Acid Decreased reporting signals
As of the last recalculation, Blood Uric Acid Decreased appears in 481 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 152.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 28 | 152.5 | 153.0 |
| Dimenhydrinate | 29 | 125.3 | 125.6 |
| Standardized Senna Concentrate | 28 | 102.2 | 102.4 |
| Febuxostat | 20 | 53.8 | 53.9 |
| Febuxostat Tablets 40 Mg | 11 | 47.9 | 47.9 |
| Febuxostat Tablets 80 Mg | 11 | 47.9 | 47.9 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 20.2 | 20.2 |
| Entecavir | 5 | 18.7 | 18.7 |
| Trastuzumab | 28 | 18.7 | 18.7 |
| Canagliflozin | 10 | 14.7 | 14.8 |
| Guselkumab | 10 | 12.3 | 12.3 |
| Romosozumab-Aqqg | 3 | 9.6 | 9.6 |